No Data
No Data
The American Diabetes Association and Xeris Pharmaceuticals Announce National Collaboration to Provide Life-Saving Hypoglycemia Education and Awareness
Analysts Offer Insights on Healthcare Companies: Xeris Pharmaceuticals (XERS), Quanterix (QTRX) and Walgreens Boots Alliance (WBA)
Craig-Hallum Maintains Xeris Pharmaceuticals(XERS.US) With Buy Rating
Xeris Pharmaceuticals (XERS) Receives a Buy From Craig-Hallum
Xeris Biopharma Expects To Generate 2024 Revenue Of $203M, Exceeding Previous Guidance Of $198M-$202M Versus Consensus Of $199.70M, With Over $71M In Cash, Cash Equivalents, And Short-term Investments, Generating Positive Cash Flow In The Fourth Quarter
Xeris Biopharma Sees End-2024 Cash Position Topping $71M >XERS